Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe

Abstract

Measuring the amount of HCV in the population of PWID is uncertain. To reduce HCV infection to minimal levels in Europe will require scale-up of both HCV treatment and other interventions that reduce injecting risk (especially OST and provision of sterile injecting equipment).